欧洲婴儿、儿童和孕产妇益生菌补充剂市场预测至 2028 年 - COVID-19 影响和区域分析 - 按形式（胶囊和软胶囊、软糖、液体等）和最终用户（婴幼儿、儿童）和产妇）
No. of Pages: 94 | Report Code: BMIRE00027134 | Category: Consumer Goods
No. of Pages: 94 | Report Code: BMIRE00027134 | Category: Consumer Goods
孕妇正在寻求各种替代方案来支持她们的健身和健康未出生婴儿的健康。消化问题，如便秘、腹泻、胃酸过多和炎症，在怀孕期间很常见。近年来，孕妇对益生菌膳食补充剂的需求有所增加。经过彻底研究的益生菌菌株有助于改善肠道蠕动并缓解便秘问题。在常规饮食中补充益生菌有助于减少炎症、酸度和腹胀，还可以降低阴道感染的风险，从而减少新生儿出现绞痛、湿疹和其他过敏的机会。此外，它还可以降低孕妇患先兆子痫的风险，这是一种导致高血压和尿液中高蛋白水平的健康状况。益生菌补充剂还可以确保孕妇拥有更好的免疫力，有助于对抗慢性疾病并确保婴儿的健康。嗜酸乳杆菌、两歧双歧杆菌和布拉酵母菌是产前益生菌补充剂中最有效和最广泛使用的益生菌菌株。这些菌株有助于维持健康的肠道菌群，并降低各种过敏、疾病和并发症的风险，包括妊娠糖尿病和先兆子痫。孕妇和新生儿对益生菌补充剂益处的认识不断增强，这极大地推动了婴儿、儿童和孕产妇益生菌补充剂市场的增长。
借助新功能和技术，供应商可以吸引新客户并扩大其业务范围新兴市场的足迹。这一因素可能会在预测期内推动欧洲婴儿、儿童和孕产妇益生菌补充剂市场以显着的复合年增长率增长。
分为形式、最终用户和国家/地区。根据形式，市场分为胶囊和软胶囊、软糖、液体等。根据最终用户，市场分为婴幼儿、儿童和孕产妇。按国家/地区划分，欧洲婴儿、儿童和孕产妇益生菌补充剂市场分为德国、英国、法国、意大利、俄罗斯和欧洲其他地区。
拜耳公司、雀巢公司SA、BioGaia AB 和 Nordic Naturals 是欧洲婴儿、儿童和孕产妇益生菌补充剂市场的几家主要公司。
Strategic insights for Europe Infant, Child, and Maternal Probiotic Supplements involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 179.18 Million |
| Market Size by 2028 | US$ 287.30 Million |
| Global CAGR (2022 - 2028) | 8.2% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 形式
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Infant, Child, and Maternal Probiotic Supplements refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Infant, Child, and Maternal Probiotic Supplements Market is valued at US$ 179.18 Million in 2022, it is projected to reach US$ 287.30 Million by 2028.
As per our report Europe Infant, Child, and Maternal Probiotic Supplements Market, the market size is valued at US$ 179.18 Million in 2022, projecting it to reach US$ 287.30 Million by 2028. This translates to a CAGR of approximately 8.2% during the forecast period.
The Europe Infant, Child, and Maternal Probiotic Supplements Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Infant, Child, and Maternal Probiotic Supplements Market report:
The Europe Infant, Child, and Maternal Probiotic Supplements Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Infant, Child, and Maternal Probiotic Supplements Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Infant, Child, and Maternal Probiotic Supplements Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Infant, Child, and Maternal Probiotic Supplements Market
